Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fumao Bai"'
Publikováno v:
Translational Oncology, Vol 49, Iss , Pp 102094- (2024)
Objective: PARPi offers less clinical benefit for HRP patients compared to HRD patients. PARPi has an immunomodulatory function. NRT therapy targets tumor neoantigens without off-target immune toxicity. We explored the synergy between Niraparib and N
Externí odkaz:
https://doaj.org/article/7debdf9a8f9f451984b690bc551583bc
Autor:
Jianzhong Ye, Yishuai Lin, Qing Wang, Yating Li, Yajie Zhao, Lijiang Chen, Qing Wu, Chunquan Xu, Cui Zhou, Yao Sun, Wanchun Ye, Fumao Bai, Tieli Zhou
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
BackgroundNonalcoholic steatohepatitis (NASH) is rapidly becoming a major chronic liver disease worldwide. However, little is known concerning the pathogenesis and progression mechanism of NASH. Our aim here is to identify key genes and elucidate the
Externí odkaz:
https://doaj.org/article/3d2e7d89deb04645b666ec71a38b5158
Publikováno v:
Molecular Oncology, Vol 12, Iss 7, Pp 1125-1137 (2018)
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer and the second leading cause of cancer‐related deaths worldwide. Given that the rate of HCC recurrence 5 years after liver resection is as high as 70%, patient with HCC typicall
Externí odkaz:
https://doaj.org/article/711fec641b3b47c28a781e4625566c51
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Around the world, cervical cancer is the fourth most common cancer among women. MicroRNAs (miRNAs) and agents that target mRNAs have been introduced as novel diagnostic markers and therapeutic approaches, respectively, in cancer.
Externí odkaz:
https://doaj.org/article/ca2f63343d634565b9fa7c8ce8dbcee9
Autor:
Yumin Wang, Zheng Zhou, Fumao Bai, Jian Chen, Dan Zhang, Meijuan Zhang, Han Chen, Lijiang Chen
Publikováno v:
Jundishapur Journal of Microbiology. 14
Background: The pandemic caused by the new coronavirus is overwhelming the world. Bacteria and fungi were detected in some cases, which suggested the associations between COVID-19 and bacterial and fungal infections. Objectives: To provide suggestion
Publikováno v:
Molecular Oncology, Vol 12, Iss 7, Pp 1125-1137 (2018)
Molecular Oncology
Molecular Oncology
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer and the second leading cause of cancer‐related deaths worldwide. Given that the rate of HCC recurrence 5 years after liver resection is as high as 70%, patient with HCC typicall
Autor:
Mengni Ma, Chen Guan, Gefei Li, Jianxin Lyu, Fumao Bai, Yuan Chen, Lei Fang, Jiali Zhang, Qing H. Meng
Publikováno v:
Journal of Cancer
Background: Metformin has been reported to inhibit the growth of various types of cancers, including breast cancer. Yet the mechanisms underlying the anticancer effects of metformin are not fully understood. Growing evidence suggests that metformin's
Autor:
Lingling Zhang, Chen Guan, Sixuan Wang, Fumao Bai, Mengni Ma, Qing H. Meng, Huaibin Zhou, Luye Long, Shihan Qian, Jianxin Lyu
Prostate cancer (PCa) is the second frequently newly diagnosed cancer in men. Androgen deprivation therapy has been widely used to inhibit PCa growth but eventually fails in many patients. Androgen receptor and its downstream molecules like microRNAs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::211e33e367596389cb3ebe5165fbafe6
https://europepmc.org/articles/PMC6606003/
https://europepmc.org/articles/PMC6606003/
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Background Around the world, cervical cancer is the fourth most common cancer among women. MicroRNAs (miRNAs) and agents that target mRNAs have been introduced as novel diagnostic markers and therapeutic approaches, respectively, in cancer. MiRNA-486